Non-nucleoside reverse transcriptase inhibitor (NNRTI) cross-resistance: implications for preclinical evaluation of novel NNRTIs and clinical genotypic resistance testing release_nm5knwzcgfgwllbal3r5njdm3a

by George L. Melikian, Soo-Yon Rhee, Vici Varghese, Danielle Porter, Kirsten White, Jonathan Taylor, William Towner, Paolo Troia, Jeffrey Burack, Edwin DeJesus, Gregory K. Robbins, Kristin Razzeca (+5 others)

Published in Journal of Antimicrobial Chemotherapy by Oxford University Press (OUP).

2013   Volume 69, p12-20

Archived Files and Locations

application/pdf  478.2 kB
file_lenkambqdvanxpeormtblclnnm
escholarship.org (web)
web.archive.org (webarchive)
application/pdf  478.7 kB
file_iitgnqo3f5hy5n2sg74n6b3loy
web.archive.org (webarchive)
cloudfront.escholarship.org (web)
application/pdf  450.0 kB
file_5wedoj37cra33k4eph3hsw6f6i
web.archive.org (webarchive)
hivdb.stanford.edu (web)
Read Archived PDF
Preserved and Accessible
Type  article-journal
Stage   published
Date   2013-08-09
Language   en ?
DOI  10.1093/jac/dkt316
PubMed  23934770
PMC  PMC3861329
Wikidata  Q42101552
Journal Metadata
Not in DOAJ
In Keepers Registry
ISSN-L:  0305-7453
Work Entity
access all versions, variants, and formats of this works (eg, pre-prints)
Catalog Record
Revision: 8a335aa1-d87b-43a7-a691-2f015d6159f4
API URL: JSON